GlassScriptPhysician profile
Roy C Fox
NPI 1972594208
$9,135.01
in general payments reported to CMS, 2019-2025
40 companies · $1,905 in 2025
The $1,905 reported for 2025 was more than what 86% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,501 · 2020: $759 · 2021: $1,304 · 2022: $1,101 · 2023: $1,360 · 2024: $1,206 · 2025: $1,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,448 · Education: $22.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,448.33 |
| Education | $22.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,479.49 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,411.87 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $693.85 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Genzyme Corporation | $633.29 | 2019-2025 | |
| Genentech USA, INC. | $598.06 | 2019-2025 | Xolair |
| Insmed, INC. | $538.38 | 2019-2024 | Arikayce |
| United Therapeutics Corporation | $531.18 | 2019-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $414.31 | 2021-2025 | Dupixent |
| Grifols USA, LLC | $329.78 | 2019-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $258.79 | 2021-2025 | Wakix |
| La Jolla Pharmaceutical Company | $243.87 | 2020-2023 | Giapreza |
| Mylan Specialty L.P. | $214.67 | 2019-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $166.53 | 2021-2025 | Zerbaxa, Recarbrio, Keytruda |
| Novartis Pharmaceuticals Corporation | $152.07 | 2019-2024 | |
| Aero US INC | $138.99 | 2023 | Aerogen Solo Nebulizer System, Aerogen Solo; Aerogen Ultra, Aerogen Usb Controller System |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $134.74 | 2022 | |
| Amgen INC. | $113.39 | 2024-2025 | Tezspire |
| Verona Pharma, INC. | $100.20 | 2025 | Ohtuvayre |
| Abbott Laboratories | $99.45 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Sunovion Pharmaceuticals INC. | $89.43 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.83 | 2020-2025 | Glassia |
| Tetraphase Pharmaceuticals, INC. | $77.52 | 2019-2020 | |
| Pfizer INC. | $75.56 | 2019-2022 | |
| Csl Behring | $65.48 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $64.14 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.02 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $55.56 | 2020-2022 | |
| Allergan, INC. | $48.79 | 2019-2020 | |
| Caris Mpi, INC. | $42.45 | 2025 | Mi Cancer Seek |
| Mallinckrodt Hospital Products INC. | $31.98 | 2020 | |
| Advanced Respiratory, INC | $31.16 | 2020-2021 | |
| Viatris Specialty LLC | $27.93 | 2025 | Yupelri |
| Baxter Healthcare | $25.16 | 2024 | Hillrom - Monarch Airway Clearance System |
| Inogen, INC. | $18.50 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Lilly USA, LLC | $17.04 | 2025 | Zepbound |
| Mayne Pharma Commercial LLC | $14.90 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.48 | 2020 | |
| Abbvie INC. | $12.16 | 2021 | |
| Gilead Sciences, INC. | $11.77 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.